Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Labreuche

Showing results (251-260 of 449) with videos related to

Pageof 45
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 26, 2015
Prior IV Thrombolysis Facilitates Mechanical Thrombectomy in Acute Ischemic StrokePierre Guedin, Aurelie Larcher, Jean-Pierre Decroix, et al.
Stroke|December 29, 2021
Intracranial Hemorrhage in the TST TrialPierre Amarenco, Jong S Kim, Julien Labreuche, et al.
Stroke|June 28, 2023
More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a StrokePierre Amarenco, Philippa C Lavallée, Jong S Kim, et al.
Stroke|April 18, 2009
Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic reviewElena Meseguer, Mikael Mazighi, Julien Labreuche, et al.
Angiogenesis|June 9, 2026
Soluble CD146 reflects altered endothelial and metabolic homeostasis in peripheral artery diseaseHaizam Oubari, Julien Labreuche, Charlotte Reytier, et al.
European Journal of Pediatrics|April 14, 2023
Changes in physical activity patterns from adolescence to young adulthood: the BELINDA studyJérémy Vanhelst, Laurent Béghin, Elodie Drumez, et al.
European Stroke Journal|January 28, 2020
Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokesPierre Amarenco, Jong S Kim, Julien Labreuche, et al.
Stroke|September 26, 2022
Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target TrialPierre Amarenco, Jong S Kim, Julien Labreuche, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 20, 2010
Peripheral artery disease is associated with a high CD163/TWEAK plasma ratioJuan A Moreno, Tiphaine Dejouvencel, Julien Labreuche, et al.
Journal of Neurointerventional Surgery|September 23, 2025
Acute ischemic stroke and reperfusion drive molecular immune-vascular activations detectable in peripheral bloodFrancesca Rapido, Nicola Marchi, Julien Labreuche, et al.
Pageof 45

Showing results (251-260 of 449) with videos related to

Sort By:
Pageof 45
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 26, 2015
Prior IV Thrombolysis Facilitates Mechanical Thrombectomy in Acute Ischemic StrokePierre Guedin, Aurelie Larcher, Jean-Pierre Decroix, et al.
Stroke|December 29, 2021
Intracranial Hemorrhage in the TST TrialPierre Amarenco, Jong S Kim, Julien Labreuche, et al.
Stroke|June 28, 2023
More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a StrokePierre Amarenco, Philippa C Lavallée, Jong S Kim, et al.
Stroke|April 18, 2009
Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic reviewElena Meseguer, Mikael Mazighi, Julien Labreuche, et al.
Angiogenesis|June 9, 2026
Soluble CD146 reflects altered endothelial and metabolic homeostasis in peripheral artery diseaseHaizam Oubari, Julien Labreuche, Charlotte Reytier, et al.
European Journal of Pediatrics|April 14, 2023
Changes in physical activity patterns from adolescence to young adulthood: the BELINDA studyJérémy Vanhelst, Laurent Béghin, Elodie Drumez, et al.
European Stroke Journal|January 28, 2020
Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokesPierre Amarenco, Jong S Kim, Julien Labreuche, et al.
Stroke|September 26, 2022
Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target TrialPierre Amarenco, Jong S Kim, Julien Labreuche, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 20, 2010
Peripheral artery disease is associated with a high CD163/TWEAK plasma ratioJuan A Moreno, Tiphaine Dejouvencel, Julien Labreuche, et al.
Journal of Neurointerventional Surgery|September 23, 2025
Acute ischemic stroke and reperfusion drive molecular immune-vascular activations detectable in peripheral bloodFrancesca Rapido, Nicola Marchi, Julien Labreuche, et al.
Pageof 45